Executive Team
Under the leadership of Chief Executive Officer, Mr. Enrique Conterno FibroGen’s executive team includes accomplished leaders with deep and broad experience. Supported by a staff of approximately 600 employees worldwide, we are focused on delivering first-in-class medicines for the treatment of unmet medical needs.
Enrique Conterno
Chief Executive Officer
Kirk Christoffersen
Chief Business Officer
Christine L. Chung
Senior Vice President,
China Operations
Mark Eisner, M.D.,
M.P.H.
Executive Vice President,
Chief Medical Officer
Juan Graham
Chief Financial Officer
John Hunter, Ph.D.
Chief Scientific Officer
Rahul Rajan Kaushik, Ph.D.
Senior Vice President of Pharmaceutical Development, Technical Operations and Manufacturing
Michael D. Lowenstein,
J.D.
Chief Legal Officer
Leanne C. Price, J.D.
Chief Intellectual
Property Officer
Tricia Stewart
Chief People Officer
Thane Wettig
Executive Vice President,
Chief Commercial Officer
Our Leadership